Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP874208.RAjKFeIkyAj0p7Ginniwrjc-lgNfIHtu0_gHVrq2MMan0130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP874208.RAjKFeIkyAj0p7Ginniwrjc-lgNfIHtu0_gHVrq2MMan0130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP874208.RAjKFeIkyAj0p7Ginniwrjc-lgNfIHtu0_gHVrq2MMan0130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP874208.RAjKFeIkyAj0p7Ginniwrjc-lgNfIHtu0_gHVrq2MMan0130_provenance.
- NP874208.RAjKFeIkyAj0p7Ginniwrjc-lgNfIHtu0_gHVrq2MMan0130_assertion wasGeneratedBy ECO_0000203 NP874208.RAjKFeIkyAj0p7Ginniwrjc-lgNfIHtu0_gHVrq2MMan0130_provenance.
- NP874208.RAjKFeIkyAj0p7Ginniwrjc-lgNfIHtu0_gHVrq2MMan0130_assertion wasDerivedFrom befree-20140225 NP874208.RAjKFeIkyAj0p7Ginniwrjc-lgNfIHtu0_gHVrq2MMan0130_provenance.
- NP874208.RAjKFeIkyAj0p7Ginniwrjc-lgNfIHtu0_gHVrq2MMan0130_assertion SIO_000772 17713473 NP874208.RAjKFeIkyAj0p7Ginniwrjc-lgNfIHtu0_gHVrq2MMan0130_provenance.
- NP874208.RAjKFeIkyAj0p7Ginniwrjc-lgNfIHtu0_gHVrq2MMan0130_assertion evidence source_evidence_literature NP874208.RAjKFeIkyAj0p7Ginniwrjc-lgNfIHtu0_gHVrq2MMan0130_provenance.
- NP874208.RAjKFeIkyAj0p7Ginniwrjc-lgNfIHtu0_gHVrq2MMan0130_assertion description "[After adjusting for performance status, previous platinum-containing chemotherapy and occurrence of skin rash or diarrhea during the first treatment cycle in patients with performance status 0 or 1 (N=139), the absence of EGFR*1 was associated with significantly better survival (hazard ratio: 0.54; 95% confidence interval: 0.32-0.91; P=0.015).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP874208.RAjKFeIkyAj0p7Ginniwrjc-lgNfIHtu0_gHVrq2MMan0130_provenance.
- befree-20140225 importedOn "2014-02-25" NP874208.RAjKFeIkyAj0p7Ginniwrjc-lgNfIHtu0_gHVrq2MMan0130_provenance.